These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10165311)

  • 1. Is Helicobacter pylori eradication a cost-effective treatment of duodenal ulcer disease?
    Carrere MO; Lamouliatte H; Ruszniewski P
    Pharmacoeconomics; 1997 Mar; 11(3):216-24. PubMed ID: 10165311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of different strategies for treating duodenal ulcer. Helicobacter pylori eradication versus antisecretory treatment.
    Badia X; Segú JL; Ollé A; Brosa M; Monés J; García Ponte L
    Pharmacoeconomics; 1997 Apr; 11(4):367-76. PubMed ID: 10166411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
    Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
    Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer].
    Fernández Muñoz J; López de Andrés A; Zapater Hernández P; Abad Santos F
    An Med Interna; 1998 Oct; 15(10):515-22. PubMed ID: 9844225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Helicobacter pylori in duodenal ulcer: a cost-effectiveness analysis.
    García-Altés A; Jovell AJ; Serra-Prat M; Aymerich M
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1631-8. PubMed ID: 11121912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
    Craig AM; Davey P; Malek M; Murray F
    Pharmacoeconomics; 1996 Jul; 10(1):79-92. PubMed ID: 10160472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden.
    Unge P; Jönsson B; Stålhammar NO
    Pharmacoeconomics; 1995 Nov; 8(5):410-27. PubMed ID: 10160075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
    Cutler AF; Vakil N
    Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost analysis of alternative treatments for duodenal ulcer.
    Imperiale TF; Speroff T; Cebul RD; McCullough AJ
    Ann Intern Med; 1995 Nov; 123(9):665-72. PubMed ID: 7574221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of Helicobacter pylori eradication for the treatment of duodenal ulcer disease in Japan: a decision analysis to assess eradication strategy in comparison with a conventional strategy.
    Habu Y; Inokuchi H; Kiyota K; Hayashi K; Watanabe Y; Kawai K; Stålhammar NO
    J Gastroenterol Hepatol; 1998 Mar; 13(3):280-7. PubMed ID: 9570241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
    O'Brien B; Goeree R; Mohamed AH; Hunt R
    Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit study].
    Rollán A; Giancaspero R; Acevedo C; Fuster F; Hola K
    Rev Med Chil; 2000 Apr; 128(4):367-77. PubMed ID: 10962853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication--a 7-year follow-up study.
    Maconi G; Sainaghi M; Molteni M; Bosani M; Gallus S; Ricci G; Alvisi V; Porro GB
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):387-93. PubMed ID: 19182682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.
    Briggs AH; Sculpher MJ; Logan RP; Aldous J; Ramsay ME; Baron JH
    BMJ; 1996 May; 312(7042):1321-5. PubMed ID: 8646042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.